Skip to Content

How is Vantrela ER formulated to be abuse deterrent?

Answers (1)

Official Answer by Drugs.com 8 Feb 2017

Vantrela ER (hydrocodone bitartrate) extended-release tablets are formulated with Teva Pharmaceutical's abuse-deterrent technology that results in properties that are expected to reduce, but not totally prevent, oral, intranasal and intravenous abuse of the drug when the tablets are manipulated. Teva's proprietary abuse-deterrent technology is based on a multi-layer gel-forming polymer coating that regulates drug release.

Votes: +0
Drugs.com free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

How does Aimovig work to prevent migraine?

Posted 3 days ago 1 answerFAQ by Drugs.com

How do you use the drug Aimovig?

Posted 3 days ago 1 answerFAQ by Drugs.com

How does the drug Lokelma work?

Posted 3 days ago 1 answerFAQ by Drugs.com

How do you take Doptelet?

Posted 3 days ago 1 answerFAQ by Drugs.com

What is the difference between Yonsa and Zytiga?

Posted 3 days ago 1 answerFAQ by Drugs.com